How can the development of cannabinoid-based therapies be guided by patient-centric approaches?
How can the development of cannabinoid-based therapies be guided by patient-centric approaches? Developing cannabinoid-based therapies can be effectively guided by patient-centric approaches that prioritize the needs and preferences of patients. Engaging patients in the research process, such as through focus groups or surveys, can provide valuable insights into their experiences, desired outcomes, and concerns regarding cannabinoid use. Moreover, tailoring cannabinoid therapies based on individual patient characteristics, including genetics, comorbidities, and personal preferences, can enhance treatment efficacy and adherence. Patient education and shared decision-making are also critical components of a patient-centric approach, ensuring that individuals are well-informed about the benefits and risks of cannabinoid therapies. By focusing on the patient experience, healthcare providers can improve the overall effectiveness and acceptance of cannabinoid treatments (Zach et al., 2021).